ExLibris header image
SFX Logo
Title: The role of D-1 and D-2 receptors
Source:

Nature [0028-0836] Schachter, M yr:1980


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Malhotra, Anil K. "D2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis." The American Journal of Psychiatry 167.7 (2010): 763-72. Link to SFX for this item
2. Zhang, M. "A meta-analysis of oxidative stress markers in schizophrenia." SCIENCE CHINA Life Sciences 53.1 (2010): 112-124. Link to SFX for this item
3. Manenschijn, L. "Clinical features associated with glucocorticoid receptor polymorphisms." Annals of the New York Academy of Sciences 1179.1 (2009): 179-198. Link to Full Text for this item Link to SFX for this item
4. He, L. "An association study of the SLC26A4 gene in children with mental retardation." Neuroscience Letters 477.2 (2009): 155-8. Link to SFX for this item
5. Dreher, J. "Variation in dopamine genes influences responsivity of the human reward system." Proceedings of the National Academy of Sciences of the United States of America 106.2 (2009): 617-622. Link to Full Text for this item Link to SFX for this item
6. Malhotra, A K K. "Benefits and pitfalls encountered in psychiatric genetic association studies." Biological Psychiatry 45.5 (1999): 544-50. Link to Full Text for this item Link to SFX for this item
7. Hariri, E E R. "Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity." Molecular psychiatry 14.1 (2007): 60-70. Link to Full Text for this item Link to SFX for this item
8. Flatow, J. "Meta-analysis of oxidative stress in schizophrenia." Biological psychiatry 74.6 (2013): 400-409. Link to SFX for this item
9. Schmack, K. "Catechol-O-methyltransferase Val(158)met genotype influences neural processing of reward anticipation." NeuroImage 42.4 (2008): 1631-1638. Link to SFX for this item
10. Peck, R. "Beyond Genetics—Stratified and Personalised Medicines Using Multiple Parameters." Pharmaceuticals 3.5 (2010): 1637-1651. Link to Full Text for this item Link to SFX for this item
11. Zhang, J. "Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia." Schizophrenia research 146.1-3 (2013): 285-288. Link to SFX for this item
12. Ming, X. "Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study." Journal of proteome research 11.12 (2012): 5856-5862. Link to Full Text for this item Link to SFX for this item
13. Bošković, M. "Oxidative stress in schizophrenia." Current neuropharmacology 9.2 (2011): 301-312. Link to Full Text for this item Link to SFX for this item
14. Adams, James B. "Nutritional and Metabolic Status of Children with Autism vs. Neurotypical Children, and the Association with Autism Severity." Nutrition & metabolism 8.1 (2011): 34-34. Link to Full Text for this item Link to SFX for this item
15. Aksenova, M G. "Allele polymorphism of the dopamine transporter gene in patients with endogenous psychoses: Association with pathological syndromes." Molecular biology 34.4 (2000): 601-605. Link to Full Text for this item Link to SFX for this item
16. Gore, John J. "Selective Potentiation of the Metabotropic Glutamate Receptor Subtype 2 Blocks Phencyclidine-Induced Hyperlocomotion and Brain Activation." Neuroscience 168.1 (2010): 209-218. Link to SFX for this item
17. Fava, L. "Multi-sensory rooms: comparing effects of the Snoezelen and the Stimulus Preference environment on the behavior of adults with profound mental retardation." Research in Developmental Disabilities 31.1: 160-71. Link to SFX for this item
18. Fabisch, H. "[Genetic risk factors in schizophrenia]." Fortschritte der Neurologie, Psychiatrie 73.Nov (2005): 44-50. Link to SFX for this item
19. Lonsdorf, T. "The genetics of fear learning: Fear conditioned startle potentiation and a polymorphism in the serotonin transporter gene." Psychophysiology 44 (2007). Link to Full Text for this item Link to SFX for this item
20. Lencz, T. "DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients." The American journal of psychiatry 163.3 (2006): 529-531. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced